Rare missense substitutions in the mitochondrial DNA genes in patients with ventricular tachycardia
Authors:
- M. V. GolubenkoMGM. V. Golubenko
- N. P. BabushkinaNBN. P. Babushkina
- V. A. KorepanovVKV. A. Korepanov
- N. R. ValiakhmetovNVN. R. Valiakhmetov
- T. A. AtabekovTAT. A. Atabekov
- K. N. VittKVK. N. Vitt
- A. A. ZarubinAZA. A. Zarubin
- O. A. MakeevaOMO. A. Makeeva
- S. A. AfanasievSAS. A. Afanasiev
- R. E. BatalovRBR. E. Batalov
- A. A. GarganeevaAGA. A. Garganeeva
- M. S. NazarenkoMNM. S. Nazarenko
Open Access
- 4 September 2025
- journal article
- Published by Institute of Cytology and Genetics, SB RAS in Vavilov Journal of Genetics and Breeding
- Vol. 29 (5) , 676-684
Abstract
Human mitochondrial DNA (mtDNA) exhibits high population-level polymorphism. While certain pathogenic mtDNA variants are known to cause hereditary mitochondrial syndromes, often presenting with cardiac arrhythmias, life-threatening ventricular tachycardia (VT) itself is a major risk factor for sudden death in cardiovascular diseases. The aim of the work was to study rare (“private”) missense substitutions in the mtDNA of patients with documented episodes of ventricular tachycardia in comparison with patients with ischemic heart disease without life-threatening heart arrhythmias and individuals without clinical manifestations of cardiovascular diseases. The sequencing of mtDNA was performed using high-throughput sequencing methods. Specialized algorithms predicting the effect of gene variants were used to assess the effect of missense substitutions. Comparative analysis of the spectrum of the identified amino acid substitutions in the studied groups showed that about 40 % of the individuals in all three groups were carriers of “private” missense variants in mtDNA. However, among such substitutions, the variants classified by the APOGEE2 predictor as “variants of uncertain significance” (VUS) were more common in the group of patients with heart arrhythmias than in the control group, where “private” missense substitutions of the VUS category were not detected (p = 0.0063 for Fisher’s exact test). In addition, the groups differed in their phred-ranked Combined Annotation Dependent Depletion (CADD) scores, which were lower for individuals in the control group. The results indicate that rare mtDNA variants may contribute to predisposition to cardiovascular disease – in particular, to the risk of developing ventricular tachycardia by some patients.Keywords
This publication has 31 references indexed in Scilit:
- Specifications of the ACMG/AMP standards and guidelines for mitochondrial DNA variant interpretationHuman Mutation, 2020
- Mitochondrial genome variations in idiopathic dilated cardiomyopathyMitochondrion, 2019
- Mitochondrial DNA variation in sudden cardiac death: a population-based studyInternational journal of legal medicine, 2019
- Functional Role of Mitochondria in Arrhythmogenesis2017
- Mitochondrial disease: genetics and managementJournal of Neurology, 2015
- Mitochondrial Cardiomyopathy and Related ArrhythmiasCardiac Electrophysiology Clinics, 2015
- MitImpact: an Exhaustive Collection of Pre-computed Pathogenicity Predictions of Human Mitochondrial Non-synonymous VariantsHuman Mutation, 2014
- Mitochondrial DNA variations associated with hypertrophic cardiomyopathyMitochondrion, 2014
- Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: Evidence for an association to haplogroup HMitochondrion, 2011
- Updated comprehensive phylogenetic tree of global human mitochondrial DNA variationHuman Mutation, 2008